D.C. Circuit Sides with Drug Makers in 340B Dispute over Contract Pharmacies
- May 24, 2024
The D.C. Circuit held May 21 that pharmaceutical companies are not obligated under the 340B statute to deliver their drugs to an unlimited number of contract pharmacies.
ARTICLE TAGS
You must be logged in to access this content.